Prediabetes and associated disorders (original) (raw)

References

M. Buysschaert, M. Bergman, Definition of prediabetes. Med. Clin. N. Am. 95(2), 289–297 (2011)
CAS PubMed Google Scholar
K. Færch, K. Borch-Johnsen, J.J. Holst, A. Vaag, Pathophysiology and aetiology of impaired fasting glycemia and impaired glucose tolerance: does it matter for prevention and treatment of type 2 diabetes? Diabetologia 52, 1714–1723 (2009)
PubMed Google Scholar
R.A. DeFronzo, M.A. Ghani, Assessment and treatment of cardiovascular risk in prediabetes: impaired glucose tolerance and impaired fasting glucose. Am. J. Cardiol. 108(Suppl), 3B–24B (2011)
CAS PubMed Google Scholar
M. Buysschaert, M. Bergman, Diagnosis of prediabetes and diabetes prevention, in Prevention of Diabetes, 1st edn., ed. by P. Schwarz, P. Reddy (Wiley, New York, 2013)
Google Scholar
M. Buysschaert, V. Preumont, J.L. Medina, M. Bergman, Global Health Perspectives in Prediabetes and Diabetes (World Scientific Publishing, Hackensack, 2014)
Google Scholar
H. Gerstein, P. Santaguida, P. Raina, K. Morrison, C. Balion, D. Hunt, H. Yazdi et al., Annual incidence and relative risk of diabetes in people with various categories of dysglycemia: a systematic review and meta-analysis of prospective studies. Diabetes Res. Clin. Pract. 78, 305–312 (2007)
PubMed Google Scholar
A.G. Tabák, C. Herder, W. Rathmann, E.J. Brunner, M. Kivimäki, Prediabetes: a high-risk state for diabetes development. Lancet 379, 2279–2290 (2012)
PubMed Central PubMed Google Scholar
E. Ferrannini: Definition of intervention points in prediabetes. Lancet (2014). doi:10.1016/s2213-8587(13)70175-x
S.M. Grundy, Pre-diabetes, metabolic syndrome and cardiovascular risk. JACC 59, 635–643 (2012)
CAS PubMed Google Scholar
J.L. Chiasson, S. Bernard, Reducing cardiovascular risk factors in patients with prediabetes. Diabetes Manag. 1(4), 423–438 (2011)
Google Scholar
L.G. Mellbin, M. Anselmino, R. Lars, Diabetes, prediabetes and cardiovascular risk. Eur. J. Cardiovasc. Prev. Rehabil. 17, S9–S14 (2010)
PubMed Google Scholar
A. Norhammar, A. Tenerz, G. Nilsson, A. Hamsten, S. Effendic, L. Ryden, G. Malmber, Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study. Lancet 359, 2140–2144 (2002)
CAS PubMed Google Scholar
S. Fonville, A.A.M. Zandbergen, S.E. Vermeer, D.W.J. Dippel, P.J. Koudstaal, H.M. den Hertog, Prevalence of prediabetes and newly diagnosed diabetes in patients with a transient ischemic attack or stroke. Cerebrovasc. Dis. 36, 283–289 (2013)
CAS PubMed Google Scholar
W.L. Lee, A.M. Cheung, D. Cape, B. Zinman, Impact of diabetes on coronary artery disease in women and men: a meta-analysis of prospective studies. Diabetes Care 23(7), 962–968 (2000)
CAS PubMed Google Scholar
R. Huxley, F. Barzi, M. Woodward, Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies. BMJ 332(7533), 73–78 (2006)
PubMed Central PubMed Google Scholar
Emerging Risk Factors Collaboration, N. Sarwar, P. Gao, S.R. Seshasai, R. Gobin, S. Kaptoge, E. Di Angelantonio et al., Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet 375, 2215–2222 (2010)
Google Scholar
E.J. Brunner, M.J. Shipley, D.R. Witte, J.H. Fuller, M.G. Marmot, Relation between blood glucose and coronary mortality over 33 years in the Whitehall Study. Diabetes Care 29(1), 26–31 (2006)
PubMed Google Scholar
B. Balkau, M. Shipley, R.J. Jarrett, K. Pyörälä, M. Pyörälä, A. Forhan, E. Eschwège, High blood glucose concentration is a risk factor mortality in middle-aged nondiabetic men. 20-year follow-up in the Whitehall Study. The Paris Prospective Study, and the Helsinki Policemen Study. Diabetes Care 21(3), 360–367 (1998)
CAS PubMed Google Scholar
M. Coutinho, H.C. Gerstein, Y. Wang, S. Yusuf, The relationship between glucose and incident cardiovascular events. Diabetes Care 22, 233–240 (1999)
CAS PubMed Google Scholar
E.L. Barr, P.Z. Zimmet, T.A. Welborn, D. Jolley, D.J. Magliano, D.W. Dunstan et al., Risk of cardiovascular and all-cause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance: the Australian Diabetes, Obesity and lifestyle Study (AusDiab). Circulation 116(2), 151–157 (2007)
CAS PubMed Google Scholar
B. Hoogwerf, D. Spreche, G. Pearce, M. Alevedo, J.P. Frolkis, J.M. Foody et al., Blood glucose concentration ≤125 mg/dl and coronary heart disease risk. Am. J. Cardiol. 89, 556–559 (2002)
Google Scholar
E.S. Ford, G. Zhao, C. Li, Pre-diabetes and the risk for cardiovascular disease. A systematic review of the evidence. J. Am. Coll. Cardiol. 55, 1310–1317 (2010)
PubMed Google Scholar
E.L.M. Barr, E.J. Boyko, P.Z. Zimmet, R. Wolfe, A.M. Tonkin, J.E. Shaw, Continuous relationship between non-diabetic hyperglycaemia and both cardiovascular disease and all-cause mortality: the Australian Diabetes, Obesity, and lifestyle (AusDiab) study. Diabetologia 52, 415–424 (2009)
CAS PubMed Google Scholar
E. Selvin, M.W. Steffes, H. Zhu, K. Matsushita, L. Wagenknecht, J. Pankow et al., Glycated hemoglobin, diabetes and cardiovascular risk in non diabetic adults. N. Engl. J. Med. 362(9), 800–811 (2010)
PubMed Central CAS PubMed Google Scholar
M. Lee, J.L. Saver, K.S. Hong, S. Song, K.H. Chang, B. Ovbiagele, Effect of pre-diabetes on future risk of stroke: meta-analysis. BMJ 344, e3564 (2012). doi:10.1136/bmj.e3564
PubMed Central PubMed Google Scholar
A. Di Pino, R. Scicali, S. Calanna, F. Urbano, C. Mantegna, A.M. Rabuazzo et al., Cardiovascular risk profile in subjects with prediabetes and new-onset type 2 diabetes identified by HbA1c according to American Diabetes Association criteria. Diabetes Care 37, 1447–1453 (2014)
PubMed Google Scholar
J. Yeboah, A.G. Bertoni, D.M. Herrington, W.S. Post, G.L. Burke, Impaired fasting glucose and the risk of incident diabetes mellitus and cardiovascular events in an adult population. J. Am. Coll. Cardiol. 58, 140–146 (2001)
Google Scholar
B. Kowall, W. Rathmann, M. Heier, G. Giani, A. Peters, B. Thorand et al., Categories of glucose tolerance and continuous glycemic measures and mortality. Eur. J. Epidemiol. 26(8), 637–645 (2011)
CAS PubMed Google Scholar
P. Deedwania, K. Patel, G.C. Fonarow, R.V. Desai, Y. Zhang, M.A. Feller et al., Prediabetes is not an independent risk factor for incident heart failure, other cardiovascular events or mortality in older adults: findings from a population-based cohort study. Int. J. Cardiol. 168(4), 3616–3622 (2013)
PubMed Central PubMed Google Scholar
K. Shaye, T. Amir, S. Shlomo, S. Yechezkel, Fasting glucose levels within the high normal range predict cardiovascular outcome. Am. Heart J. 164, 111–116 (2012)
CAS PubMed Google Scholar
For the DECODE Study Group, F. Ning, J. Tuomilehto, K. Pyörälä, A. Onat, S. Söderberg, Q. Qiao, Cardiovascular disease mortality in Europeans in relation to fasting and 2-h plasma glucose levels within a normoglycemic range. Diabetes Care 33, 2211–2216 (2010)
PubMed Central Google Scholar
K.T. Khaw, N. Wareham, R. Luben, S. Bingham, S. Oakes, A. Welch, N. Day, Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of European Prospective Investigation of Cancer and Nutrition (EPIC-Norfolk). BMJ 322, 1–6 (2001)
Google Scholar
K.T. Khaw, N. Wareham, S. Bingham, R. Luben, A. Welch, N. Day, Association of hemoglobin A1c with cardiovascular disease and mortality in adults: the European prospective investigation into cancer in Norfolk. Ann. Intern. Med. 141(6), 413–420 (2004)
CAS PubMed Google Scholar
H.C. Gerstein, S. Islam, S. Anand, W. Almahmeed, A. Damasceno, A. Dans et al., Dysglycaemia and the risk of acute myocardial infarction in multiple ethnic groups: an analysis of 15,780 patients from the INTERHEART study. Diabetologia 53, 2509–2517 (2010)
CAS PubMed Google Scholar
Q. Qiao, K. Pyörälä, M. Pyörälä, A. Nissinen, J. Lindström, R. Tilvis, J. Tuomilehto, Two-hour glucose is better risk predictor for incident coronary heart disease and cardiovascular mortality than fasting glucose. Eur. Heart J. 23(16), 1267–1275 (2002)
CAS PubMed Google Scholar
The DECODE Study Group, On behalf of the European Diabetes Epidemiology Group, Glucose tolerance and cardiovascular mortality. Comparison of fasting and 2-hour diagnostic criteria. Arch. Intern. Med. 161, 397–404 (2001)
Google Scholar
S.B. Meigs, D.M. Nathan, R.B. D’Agostino Sr, The Framingham Offspring Study. Fasting and postchallenge glycemic and cardiovascular disease risk. Diabetes Care. 25, 1845–1850 (2002)
PubMed Google Scholar
F. De Vegt, J.M. Dekker, H.G. Ruhé, C.D. Stehouwer, G. Nijpels, L.M. Bouter, R.J. Heine, Hyperglycaemia is associated with all-cause and cardiovascular mortality in the Hoorn population: the Hoorn Study. Diabetologia 42(8), 926–931 (1999)
PubMed Google Scholar
M. Tominaga, H. Eguchi, H. Manaka, K. Igarashi, T. Kato, A. Sekikawa, Impaired glucose tolerance is a risk factor for cardiovascular disease but not impaired fasting glucose. The Funagata Diabetes Study. Diabetes Care. 22(6), 920–924 (1999)
CAS PubMed Google Scholar
K. Kato, T. Otsuka, N. Kobayashi, Y. Kon, T. Kawada, Two-hour post-load plasma glucose levels are associated with carotid intima-media thickness in subjects with normal glucose tolerance. Diabet. Med. 31(1), 76–83 (2014)
CAS PubMed Google Scholar
Emerging Risk Factors Collaboration, S.R. Seshasai, S. Kaptoge, A. Thompson, E. Di Angelantonio, P. Gao, N. Sarwar et al., Diabetes mellitus, fasting glucose, and risk of cause-specific death. N. Engl. J. Med. 364(9), 829–841 (2011)
Google Scholar
J.A. Laukkanen, T.H. Makikallio, K. Ronkainen, J. Karppi, S. Kurl, Impaired fasting plasma glucose and type 2 diabetes are related to the risk of out-of-hospital sudden cardiac death and all-cause mortality. Diabetes Care 36, 1166–1171 (2012). doi:10.2337/dc12-0110
PubMed Google Scholar
Y.S. Levitzky, M.J. Pencina, R.B. D’Agostino, J.B. Meigs, J.M. Murabito, R.S. Vasan, C.S. Fox, Impact of impaired fasting glucose on cardiovascular disease. JACC 51, 264–270 (2008)
CAS PubMed Google Scholar
E. Selvin, J. Coresh, S.H. Golden, F.L. Brancati, A.R. Folsom, M.W. Steffes, Glycemic control and coronary heart disease risk in persons with and without diabetes: the atherosclerosis risk in communities study. Arch. Intern. Med. 165(16), 1910–1916 (2005)
PubMed Google Scholar
N. Sarwar, T. Aspelund, G. Eiriksdottir, R. Gobin, S.R. Seshasai, N.G. Forouhi et al., Markers of dysglycaemia and risk of coronary heart disease in people without diabetes: Reykjavik prospective study and systematic review. PLoS Med. 7(5), e1000278 (2010). doi:10.1371/journal.pmed.1000278
PubMed Central PubMed Google Scholar
M.V. Skriver, K. Borch-Johnsen, T. Lauritzen, HbA1c as predictor of all-cause mortality in individuals at high risk of diabetes with normal glucose tolerance, identified by screening: a follow-up study of the Anglo-Danish-Dutch Study of Intensive Treatment in People with Screen-Detected Diabetes in Primary Care (ADDITION), Denmark. Diabetologia 53(11), 2328–2333 (2010)
CAS PubMed Google Scholar
K. Faerch, D. Vistisen, N. Johansen Borup, M.E. Jorgensen, Cardiovascular risk stratifications and management in prediabetes. Curr. Diab. Rep. 14, 493 (2014)
PubMed Google Scholar
S. Kodama, K. Saito, S. Tanaka et al., Fasting and post-challenge glucose as quantitative cardiovascular risk factors: a meta-analysis. J. Atheroscler. Thromb. 19, 385–396 (2012)
CAS PubMed Google Scholar
A.S. Gami, B.J. Witt, D.E. Howard et al., Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. J. Am. Coll. Cardiol. 49, 403–414 (2007)
CAS PubMed Google Scholar
S. Mottillo, K.B. Filion, J. Genest et al., The metabolic syndrome and cardiovascular risk : a systematic review and meta-analysis. J. Am. Coll. Cardiol. 56, 1113–1132 (2010)
PubMed Google Scholar
Y. Zhang, E.T. Lee, R.B. Devereux, J. Yeh, L.G. Best, R.R. Fabsitz, B.V. Howard, Prehypertension diabetes and cardiovascular disease risk in a population-based sample: the Strong Heart Study. Hypertension 47, 410–414 (2006)
CAS PubMed Google Scholar
S. Milman, J.P. Crandall, Mechanisms of vascular complications in prediabetes. Med. Clin. N. Am. 95, 309–325 (2011)
CAS PubMed Google Scholar
J. Tuomilehto, J. Lindström, J.G. Eriksson, T.T. Valle, H. Hämäläinen, P. Ilanne-Parikka et al., Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N. Engl. J. Med. 344(18), 1343–1350 (2001)
CAS PubMed Google Scholar
R. Ratner, R. Goldberg, S. Haffner, S. Marcovina, T. Orchard, S. Fowler, Impact of intensive lifestyle and metformin therapy on cardiovascular disease risk factors in the diabetes prevention program. Diabetes Care 28(4), 888–894 (2005)
PubMed Google Scholar
W.C. Knowler, E. Barrett-Connor, S.E. Fowler, R.F. Hammam, J.M. Lachin, E.A. Walker et al., Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N. Engl. J. Med. 346(6), 393–403 (2002)
CAS PubMed Google Scholar
T. Orchard, M. Temprosa, E. Barrett-Connor et al., Long-term effects of the Diabetes Prevention Program interventions on cardiovascular risk factors: a report from the DPP Outcomes Study. Diabet. Med. 30, 46–55 (2013)
PubMed Central CAS PubMed Google Scholar
F.B. Hu, M.J. Stampfer, S.M. Haffner, C.G. Solomon, W.C. Willett, J.E. Manson, Elevated risk of cardiovascular disease prior to clinical diagnosis of type 2 diabetes. Diabetes Care 25(7), 1129–1134 (2002)
PubMed Google Scholar
J.L. Chiasson, R.G. Josse, R. Gomis, M. Hanefeld, A. Karasik, M. Laakso, Acarbose treatment and risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance. The STOP-NIDDM trial. JAMA. 290, 486–494 (2003)
CAS PubMed Google Scholar
E. Lonn, H. Gerstein, P. Sheridan, For the DREAM and STARR Investigations et al., Effect of ramipril and of rosiglitazone on carotid intima-media thickness in people with impaired glucose tolerance or impaired fasting glucose: STARR (Study of Atherosclerosis with Ramipril and Rosiglitazone). J. Am. Coll. Cardiol. 53, 2028–2035 (2009)
CAS PubMed Google Scholar
E.M. Lonn, J. Bosch, R. Diaz, P. Lopez-Jaramillo, A. Ramachandran, N. Hâncu et al., Effect of insulin glargine and n-3FA on carotid intima-media thickness in people with dysglycemia at high risk for cardiovascular events : the glucose reduction and atherosclerosis continuing evaluation study (ORIGIN-GRACE). Diabetes Care 36(9), 2466–2474 (2013)
PubMed Central CAS PubMed Google Scholar
I. Hopper, B. Billah, M. Skiba, H. Krum, Prevention of diabetes and reduction in major cardiovascular events in studies of subjects with prediabetes: meta-analysis of randomised controlled clinical trials. Eur. J. Cardiovasc. Prev. Rehabil. 18(6), 813–823 (2011)
PubMed Google Scholar
G. Li, P. Zhang, J. Wang, Y. An, Q. Gong, E.W. Gregg et al., Cardiovascular mortality, all-cause mortality, and diabetes incidence after lifestyle intervention for people with impaired glucose tolerance in the Da Qing Diabetes Prevention Study: a 23-year follow-up study. Lancet 28, 88–136 (2014). doi:10.1016/s2213-8587(14)70057-9
Google Scholar
M. Bergman, M. Buysschaert, P.E.H. Schwarz, A. Albright, V. Narayan, D. Yach, Diabetes prevention: global health policy and perspectives from the ground. Diabetes Manag. 2(4), 309–321 (2012)
CAS Google Scholar
L. Rydén et al., Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD): ESC guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with EASD. Eur. Heart J. 34, 3035–3087 (2013)
PubMed Google Scholar
American Diabetes Association, Standards of medical care in diabetes—2014. Diabetes Care 37(Suppl. 1), s14 (2014)
Google Scholar
P.M. Kearney, L. Blackwell, R. Collins, A. Keech, J. Simes, R. Peto et al., Efficacy of cholesterol-lowering therapy in 18.686 people with diabetes in 14 randomised trials of statins: a meta-analysis. Lancet 371, 117–125 (2008)
CAS PubMed Google Scholar
P.M. Ridker, E. Danielson, F.A. Fonseca et al., JUPITER Study Group: rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N. Engl. J. Med. 359, 2195–2207 (2008)
CAS PubMed Google Scholar
P.M. Preshaw, A.L. Alba, D. Herrera, S. Jepsen, A. Konstantinidis, K. Makrilakis, R. Taylor, Periodontitis and diabetes: a two-way relationship. Diabetelogia 55, 21–31 (2012)
CAS Google Scholar
F. Javed, A.S.T. Alghamdi, T. Mikami, A. Mehmood, H.B. Ahemed, L.P. Samaranayake, H.C. Tenenbaum, Effect of glycemic control on self-perceived oral health, periodontal parameters, and alveolar bone loss among patients with prediabetes. J. Periodontol. 85, 234–241 (2014)
CAS PubMed Google Scholar
N. Arora, P.N. Papapanou, M. Rosenbaum, D.R. Jacobs Jr, M. Desvarieux, R.T. Demmer, Periodontal infection, impaired fasting glucose and impaired glucose tolerance: results from The Continuous National Health and Nutrition Examination Survey 2009–2010. J. Clin. Periodontol. 41, 643–652 (2014)
CAS PubMed Google Scholar
C.C.P. Andersen, A. Flyvbjerg, K. Buschard, P. Holmstrup, Periodontitis is associated with aggravation of prediabetes in Zucker fatty rats. J. Periodontol. 71, 1625–1631 (2007)
Google Scholar
M. Manouchehr-Pour, P.J. Spagnuolo, H.M. Rodman, N.F. Bissada, Comparison of neutrophil chemotactic response in diabetic patients with mild and severe periodontal disease. J. Periodontol. 52, 410–415 (1981)
CAS PubMed Google Scholar
M. Altamash, S. Arledal, B. Klinge, P.-E. Engström, Pre-diabetes and diabetes: medical risk factors and periodontal conditions. Acta Odontol. Scand. 71, 1625–1631 (2013)
PubMed Google Scholar
R. McCrimmon, C.M. Ryan, M. Frier, Diabetes and cognitive dysfunction. Lancet 379, 2291–2299 (2012)
PubMed Google Scholar
T. Cukierman-Yaffe, Diabetes, dysglycemia & cognitive dysfunction. Diabetes Metab. Res. Rev. 30(5), 341–345 (2014)
PubMed Google Scholar
D.D. Schwartz, M.E. Axelrad, B.J. Andersen, Neurocognitive function in children and adolescents at the time of type 1 diabetes diagnosis: associations with glycemic control 1 year after diagnosis. Diabetes Care 37(9), 2475–2482 (2014)
CAS PubMed Google Scholar
C. Dufouil, C. Brayne, The continuing challenge of turning promising observational evidence about risk for dementia to evidence supporting prevention. JAMA Intern. Med. 174, 333–335 (2014)
PubMed Google Scholar
P.J.J. Spauwen, C.D.A. Stehouwer, Cognitive decline in type 2 diabetes. Lancet Diabetes Endocrinol. 2, 188–189 (2013). doi:10.1016/S2213-8587(13)70167-0
PubMed Google Scholar
J.S. Roriz-Filho, T.M. Sá-Roriz, I. Rosset, A.L. Camozzato, A.C. Santos, M.L.F. Chaves, J.C. Moriguti, M. Roriz-Cruz, (Pre)diabetes, brain aging, and cognition. Biochim. Biophys. Acta 1792, 432–443 (2009)
CAS Google Scholar
R.H. Tuligenga, A. Dugravot, A.G. Tabák, A. Elbaz, E.J. Brunner, M. Kivimäki, A. Singh-Manoux, Midlife type 2 diabetes and poor glycaemic control as risk factors for cognitive decline in early old age: a post hoc analysis of the Whitehall II cohort study. Lancet (2013). doi:10.1016/S2213-8587(13)70192-X
PubMed Google Scholar
G.J. Biessels, Intensive glucose lowering and cognition in type 2 diabetes. Lancet Neurol. 10, 949–950 (2011)
PubMed Google Scholar
L. Kerti, A.V. Witte, A. Winkler, U. Grittner, D. Rujescu, A. Flöel, Higher glucose levels associated with lower memory and reduced hippocampal microstructure. Neurology 81, 1746–1753 (2013)
CAS PubMed Google Scholar
C. Anderson et al., Glucose intolerance and diabetes as risk factors for cognitive impairment in people at high cardiovascular risk: results from the ONTARGET/TRANSCEND Research Programme. Diabetes Res. Clin. Pract. 83(3), 387–393 (2009)
PubMed Google Scholar
C.M. Sanz, J.-B. Ruidavets, V. Bongard, J.-C. Marquié, H. Hanaire, J. Ferrières, S. Andrieu, Relationship between markers of insulin resistance, markers of adiposity, HbA1c, and cognitive functions in a middle-aged population-based sample: the MONA LISA Study. Diabetes Care 36(6), 1512–1521 (2013)
PubMed Central CAS PubMed Google Scholar
Z.S. Tan, A.S. Beiser, C.S. Fox et al., Association of metabolic dysregulation with volumetric brain magnetic resonance imaging and cognitive markers of subclinical brain aging in middle-aged adults: the Framingham Offspring Study. Diabetes Care 34, 1766–1770 (2011)
PubMed Central PubMed Google Scholar
M. Nazaribadie, K. Asgari, M. Amini, M. Ahmadpanah, M. Nazarbadie, S. Jamlipaghale, Cognitive processes and functions in patients with type 2 diabetes in comparison to pre-diabetic patients. JRHS 13(2), 208–213 (2013)
PubMed Google Scholar
T. Ohara, Y. Doi, T. Ninomiya et al., Glucose tolerance status and risk off dementia in the community: the Hisayama Study. Neurology 77, 1126–1134 (2011)
CAS PubMed Google Scholar
P.K. Crane, R. Walker, R.A. Hubbard, G. Li, D.M. Nathan, H. Zheng, S. Haneuse, S. Craft, T.J. Montine, S.E. Kahn, W. McCormick, S.M. McCurry, J.D. Bowen, E.B. Larson, Glucose levels and risk of dementia. N. Engl. J. Med. 369, 540–548 (2013)
PubMed Central CAS PubMed Google Scholar
P.G. Lee, C.T. Cigolle, J. Ha, L. Min, S.L. Murphy, C.S. Blaum, W.H. Herman, Physical function limitations among middle-aged and older adults with prediabetes. Diabetes Care 36(10), 3076–3083 (2013)
PubMed Central PubMed Google Scholar
A.L. Christman, K. Matsushita, R.F. Gottesman, T. Mosley, A. Alonso, J. Coresh, F. Hill-Briggs, A.R. Sharrett, E. Selvin, Glycated haemoglobin and cognitive decline: the Atherosclerosis Risk in Communities (ARIC) study. Diabetologia 54, 1645–1652 (2011)
PubMed Central CAS PubMed Google Scholar
A.M. Jacobson, Diabetes and cognitive performance: a story that is still unfolding. Diabetologia 54, 1593–1595 (2011)
CAS PubMed Google Scholar
S.G.C. van Elderen, A. deRoos, A.J.M. de Craen et al., Progression of brain atrophy and cognitive decline in diabetes mellitus: a 3-year follow-up. Neurology 75, 997–1002 (2010)
PubMed Google Scholar
R.O. Roberts, D.S. Knopman, S.A. Przybelski et al., Association of type 2 diabetes with brain atrophy and cognitive impairment. Neurology (2014). doi:10.1212/WNL.0000000000000269
Google Scholar
G.J. Biessels, S. Staekenborg, E. Brunner, C. Brayne, P. Scheltens, Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol. 5, 64–74 (2006)
PubMed Google Scholar
R.N. Bryan, M. Bilello, C. Davatzikos, R.M. Lazar, A. Murray, K. Horowitz, J. Lovato, M.E. Miller, J. Williamson, L.J. Launer, Effect of diabetes on brain structure: the action to control cardiovascular risk in diabetes MR imaging baseline data. Radiology 271(1), 210–216 (2014)
Google Scholar
A. Kleinridders, H.A. Ferris, W. Cai, C.R. Kahn, Insulin action in brain regulates systemic metabolism and brain function. Diabetes 63(7), 2232–2243 (2014)
PubMed Google Scholar
A. Elbaz, M.J. Shipley, H. Nabi, E.J. Brunner, M. Kivimäki, A. Singh-Manoux, Trajectories of the Framingham general cardiovascular risk profile in midlife and poor motor function later in life: The Whitehall II study. Int. J. Cardiol. 172, 96–102 (2014). doi:10.1016/j.ijcard.2013.12.051
PubMed Central PubMed Google Scholar
L.J. Launer, M.E. Miller, J.D. Williamson, R.M. Lazar, H.C. Gertsein, A.M. Murray, M. Sullivan, K.R. Horowitz, J. Ding, S. Marcovina, L.C. Lovato, J. Lovato, K.L. Margolis, P. O’Connor, E.E. Lipkin, J. Hirsch, L. Coker, J. Maldjian, J.L. Sunshine, C. Truwit, C. Davatzikos, R.N. Bryan, For the ACCORD MIND investigators, Effects of intensive glucose lowering on brain structure and function in people with type 2 diabetes (ACCORD MIND):a randomized open-label substudy. Lancet Neurol. 10, 969–977 (2011)
PubMed Central PubMed Google Scholar
J.D. Williamson, L.J. Launer, R.N. Bryan, L.H. Coker, R.M. Lazar, H.C. Gerstein, A.M. Murray, M.D. Sullivan, K.R. Horowitz, S. Marcovina, L.C. Lovato, J. Lovato, K.L. Margolis, C. Davatzikos, J. Barzilay, H.N. Ginsberg, P.E. Linz, M.E. Miller, For the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Memory in Diabetes (MIND) investigators, Cognitive function and brain structure in persons with type 2 diabetes mellitus after intensive lowering of blood pressure and lipid levels. JAMA Intern. Med. 174(3), 24–333 (2014)
Google Scholar
C.D. Saudek, W.H. Herman, D.B. Sacks, R.M. Bergenstal, D. Edelman, M.B. Davidson, A new look at screening and diagnosing diabetes mellitus. J. Clin. Endocrinol. Metab. 93(7), 2447–2453 (2008)
CAS PubMed Google Scholar
S. Ghosh, A. Collier, T. Elhadd, I. Malik, Retinopathy in diabetes. Br. J. Diabetes Vasc. Dis. 10(3), 155–156 (2010)
Google Scholar
T.Y. Wong, G. Liew, R.J. Tapp, M.I. Schmidt, J.J. Wang, P. Mitchell, R. Klein, B.E. Klein, P. Zimmet, J. Shaw, Relation between fasting glucose and retinopathy for diagnosis of diabetes: three population-based cross-sectional studies. Lancet 371, 736–743 (2008)
PubMed Central CAS PubMed Google Scholar
Y.J. Cheng, E.W. Gregg, L.S. Geiss, G. Imperatore, D.E. Williams, X. Zhang, A.L. Albright, C.C. Cowie, R. Klein, J.B. Saaddine, Association of A1c and fating plasma glucose levels with diabetic retinopathy prevalence in the U.S. population. Diabetes Care 32(11), 2027–2032 (2009)
PubMed Central CAS PubMed Google Scholar
Diabetes Prevention Program Research Group, The prevalence of retinopathy un impaired glucose tolerance and recent-onset diabetes in the Diabetes Prevention Program. Diabet. Med. 24, 137–144 (2007)
PubMed Central Google Scholar
T.T. Nguyen, J.J. Wang, T.Y. Wong, Reinal vascular changes in pre-diabetes and prehypertension. Diabetes Care 30(10), 2708–2715 (2007)
PubMed Google Scholar
N. Papanas, A.I. Vinik, D. Ziegler, Neuropathy in prediabetes: does the clovk start ticking early? Nat. Rev. Endocrinol. 7, 682–690 (2011)
CAS PubMed Google Scholar
C.J. Sumner, S. Sheth, J.W. Griffin, D.R. Cornblath, M. Polydefkis, The spectrum of neuropathy in diabetes and impaired glucose tolerance. Neurology 60, 108–111 (2003)
CAS PubMed Google Scholar
B.W.C. Bongaerts, W. Rathmann, M. Heier, B. Kowall, C. Herder, D. Stöckl, C. Meisinger, D. Ziegler, Older subjects with diabetes and prediabetes are frequently unaware of having distal sensorimotor polyneuropathy. Diabetes Care 36(5), 1141–1146 (2013)
PubMed Central PubMed Google Scholar
L.C. Plantinga, D.C. Crews, J. Coresh, E.R. Miller, R. Saran, J. Yee, E. Hedgeman, M. Pavkov, M.S. Eberhardt, D.E. Williams, N.R. Powe, For the CDC CKD Surveillance team, Prevalence of chronic kidney disease in U.S. adults with undiagnosed diabetes or prediabetes. Clin. J. Am. Soc. Nephrol. 5, 673–682 (2010)
PubMed Central PubMed Google Scholar
H. Kramer, Screening for kidney disease in adults with diabetes and prediabetes. Curr. Opin. Nephrol. Hypertens. 14, 249–252 (2005)
PubMed Google Scholar
G.C. Curhan, Prediabetes, prehypertension…Is it time for pre-CKD? Clin. J. Am. Soc. Nephrol. 5, 557–559 (2010)
PubMed Google Scholar
O. Schnell, E. Standl, Impaired glucose tolerance, diabetes, and cardiovascular disease. Endocr. Pract. 12(1), 16–19 (2006)
PubMed Google Scholar
E.J. Diamantopoulos, E.A. Andreadis, G.I. Tsourous, P.M. Katsanou, D.X. Georgiopoulos, N.C. Nestora, S.A. Raptis, Early vascular lesions in subjects with metabolic syndrome and prediabetes. Int. Angiol. 25(2), 179–183 (2006)
CAS PubMed Google Scholar
J.B. Meigs, M.G. Larson, R.B. D’Agostino, D. Levy, M.E. Clouse, D.M. Nathan, P.W. Wilson, C.J. O’Donnell, Coronary artery calcification in type 2 diabetes and insulin resistance: the Framingham offspring study. Diabetes Care 25(8), 1313–1319 (2002)
CAS PubMed Google Scholar
M.W. Millar-Craig, C.N. Bishop, E.B. Raftery, Circadian variation of blood-pressure. Lancet 1(8075), 795–797 (1978)
CAS PubMed Google Scholar
A.K. Gupta, F.L. Greenway, G. Cornelissen, W. Pan, F. Halberg, Prediabetes is associated with abnormal circadian blood pressure variability. J. Hum. Hypertens. 22(9), 627–633 (2008)
PubMed Central CAS PubMed Google Scholar
W.B. White, Relevance of blood pressure variation in the circadian onset of cardiovascular events. J. Hypertens. 21(6), S9–S15 (2003)
CAS Google Scholar
R.C. Hermida, D.E. Ayala, F. Portaluppi, Circadian variation of blood pressure: the basis for the chronotherapy of hypertension. Adv. Drug Deliv. Rev. 59(9–10), 904–922 (2007)
CAS PubMed Google Scholar
W.B. White, How well does ambulatory blood pressure predict target-organ disease and clinical outcome in patients with hypertension? Blood Press. Monit. 4(2), S17–S21 (1999)
PubMed Google Scholar
O. Torffvit, C.D. Agardh, Day and night variation in ambulatory blood pressure in type 1 diabetes mellitus with nephropathy and autonomic neuropathy. J. Intern. Med. 233(2), 131–137 (1993)
CAS PubMed Google Scholar
F.S. Nielsen, P. Rossing, L.E. Bang, T.L. Svendsen, M.A. Gall, U.M. Smidt, H.H. Parving, On the mechanisms of blunted nocturnal decline in arterial blood pressure in NIDDM patients with diabetic nephropathy. Diabetes 44(7), 783–789 (1995)
CAS PubMed Google Scholar
V. Spallone, M.R. Maiello, R. Morganti, S. Mandica, G. Frajese, Usefulness of ambulatory blood pressure monitoring in predicting the presence of autonomic neuropathy in type I diabetic patients. J. Hum. Hyperten. 21(7), 381–386 (2007)
CAS Google Scholar
S. Nakano, M. Fukuda, F. Hotta, T. Ito, T. Ishii, M. Kitazawa, M. Nishizawa, T. Kigoshi, K. Uchida, Reversed circadian blood pressure rhythm is associated with occurrence of both fatal and nonfatal vascular events in NIDDM subjects. Diabetes 47(9), 1501–1506 (1998)
CAS PubMed Google Scholar
A.K. Gupta, G. Cornelissen, F.L. Greenway, V. Dhoopati, F. Halberg, W.D. Johnson, Abnormalities in circadian blood pressure variability and endothelial function: pragmatic markers for adverse cardiometabolic profiles in asymptomatic obese adults. Cardiovasc. Diabetol. (2010). doi:10.1186/1475-2840-9-58
PubMed Central PubMed Google Scholar
B. Isak, B. Oflazoglu, T. Tanridag, I. Yitmen, O. Us, Evaluation of peripheral and autonomic neuropathy among patients with newly diagnosed impaired glucose tolerance. Diabetes Metab. Res. Rev. 24(7), 563–569 (2008)
PubMed Google Scholar
S. Kumarasamy, K. Gopalakrishnan, D.H. Kim, N.G. Abraham, W.D. Johnson, B. Joe, A.K. Gupta, Dysglyceia induces abnormal circadian blood pressure variability. Cardiovasc. Diabetol. (2011). doi:10.1186/1475-2840-10-104
PubMed Central PubMed Google Scholar
Z. Putz, N. Németh, I. Istenes, T. Martos, R.A. Gandhi, A.E. Körei, Z. Hermányi, M. Szathmári, G. Jermendy, S. Tesfaye, Á.G. Tabák, P. Kempler, Autonomic dysfunction and circadian blood pressure variations in people with impaired glucose tolerance. Diabet. Med. 30(3), 358–362 (2013)
CAS PubMed Google Scholar
J.E. Shaw, N.M. Punjabi, J.P. Wilding, K.G. Alberti, P.Z. Zimmet, Sleep-disordered breathing and type 2 diabetes: a report from the International Diabetes Federation Taskforce on Epidemiology and Prevention. Diabetes Res. Clin. Pract. 81(1), 2–12 (2008)
PubMed Google Scholar
S.R. Coughlin, L. Mawdsley, J.A. Mugarza, P.M. Calverley, J.P. Wilding, Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome. Eur. Heart J. 25(9), 735–741 (2004)
PubMed Google Scholar
N.M. Punjabi, E. Shahar, S. Redline, D.J. Gottlieb, R. Givelber, H.E. Resnick, Sleep-disordered breathing, glucose intolerance, and insulin resistance: the Sleep Heart Health Study. Am. J. Epidemiol. 160(6), 521–530 (2004)
PubMed Google Scholar
S. Seicean, H.L. Kirchner, D.J. Gottlieb, N.M. Punjabi, H. Resnick, M. Sanders, R. Budhiraja, M. Singer, S. Redline, Sleep-disordered breathing and impaired glucose metabolism in normal-weight and overweight/obese individuals: the Sleep Heart Health Study. Diabetes Care 31(5), 1001–1006 (2008)
PubMed Google Scholar
I. Muraki, T. Tanigawa, K. Yamagishi, S. Sakurai, T. Ohira, H. Imano, A. Kitamura, M. Kiyama, S. Sato, T. Shimamoto, M. Konishi, H. Iso, Nocturnal intermittent hypoxia and the development of type 2 diabetes: the Circulatory Risk in Communities Study (CIRCS). Diabetologia 53(3), 481–488 (2010)
CAS PubMed Google Scholar
N. Botros, J. Concato, V. Mohsenin, B. Selim, K. Doctor, H.K. Yaggi, Obstructive sleep apnea as a risk factor for type 2 diabetes. Am. J. Med. 122(12), 1122–1127 (2009)
PubMed Central PubMed Google Scholar
T. Kendzerska, A.S. Gershon, G. Hawker, G. Tomlinson, R.S. Leung, Obstructive sleep apnea and incident diabetes. A historical cohort study. Am. J. Respir. Crit. Care Med. 190(2), 218–225 (2014)
PubMed Google Scholar
S. Pamidi, E. Tasali, Obstructive sleep apnea and type 2 diabetes: is there a link? Front. Neurol. 3, 126 (2012). doi:10.3389/fneur.2012.00126
PubMed Central PubMed Google Scholar
O. Alshaarawy, S. Teppala, A. Shankar, Markers of sleep-disordered breathing and prediabetes in US adults. Int. J. Endocrinol. (2012). doi:10.1155/2012/902324
PubMed Central PubMed Google Scholar
N. Cheng, W. Cai, M. Jiang, S. Wu, Effect of hypoxia on blood glucose, hormones, and insulin receptor functions in newborn calves. Pediatr. Res. 41(6), 852–856 (1997)
CAS PubMed Google Scholar
J.P. Chaput, J.P. Despres, C. Bouchard, A. Tremblay, Short sleep duration is associated with reduced leptin levels and increased adiposity: results from the Quebec family study. Obesity 15(1), 253–261 (2007)
CAS PubMed Google Scholar
N. Peled, A. Greenberg, G. Pillar, O. Zinder, N. Levi, P. Lavie, Contributions of hypoxia and respiratory disturbance index to sympathetic activation and blood pressure in obstructive sleep apnea syndrome. Am. J. Hypertens. 11(11), 1284–1289 (1998)
CAS PubMed Google Scholar
D. Einhorn, D.A. Stewart, M.K. Erman, N. Gordon, A. Philis-Tsimikas, E. Casal, Prevalence of sleep apnea in a population of adults with type 2 diabetes mellitus. Endocr. Pract. 13(4), 355–362 (2007)
PubMed Google Scholar
G.D. Foster, M.H. Sanders, R. Millman, G. Zammitt, K.E. Borradaile, A.B. Newman, T.A. Wadden, D. Kelley, R.R. Wing, F.X. Sunyer, V. Darcey, S.T. Kuna, Obstructive sleep apnea among obese patients with type 2 diabetes. Diabetes Care 32(6), 1017–1019 (2009)
PubMed Central PubMed Google Scholar
R.S. Aronsohn, H. Whitmore, E. Van Cauter, E. Tasali, Impact of untreated obstructive sleep apnea on glucose control in type 2 diabetes. Am. J. Respir. Crit. Care Med. 181(5), 507–513 (2010)
PubMed Central PubMed Google Scholar
R.N. Aurora, N.M. Punjabi, Obstructive sleep apnoea and type 2 diabetes mellitus: a bidirectional association. Lancet Respir. Med. 1(4), 329–338 (2013)
PubMed Google Scholar
J.M. Fredheim, J. Rollheim, T. Omland, D. Hofsø, J. Røislien, K. Vegsgaard, J. Hjelmesæth, Type 2 diabetes and pre-diabetes are associated with obstructive sleep apnea in extremely obese subjects: a cross-sectional study. Cardiovasc. Diabetol. (2011). doi:10.1186/1475-2840-10-84
PubMed Central PubMed Google Scholar
P. Levy, M.R. Bonsignore, J. Eckel, Sleep, sleep-disordered breathing and metabolic consequences. Eur. Respir. J. 34(1), 243–260 (2009)
CAS PubMed Google Scholar
I.A. Harsch, S.P. Schahin, K. Brückner, M. Radespiel-Tröger, F.S. Fuchs, E.G. Hahn, P.C. Konturek, T. Lohmann, J.H. Ficker, The effect of continuous positive airway pressure treatment on insulin sensitivity in patients with obstructive sleep apnoea syndrome and type 2 diabetes. Respiration 71(3), 252–259 (2004)
PubMed Google Scholar
H.A. Hassaballa, A. Tulaimat, J.J. Herdegen, B. Mokhlesi, The effect of continuous positive airway pressure on glucose control in diabetic patients with severe obstructive sleep apnea. Sleep Breath. 9(4), 176–180 (2005)
PubMed Google Scholar
A.R. Babu, J. Herdegen, L. Fogelfeld, S. Shott, T. Mazzone, Type 2 diabetes, glycemic control, and continuous positive airway pressure in obstructive sleep apnea. Arch. Intern. Med. 165(4), 447–452 (2005)
PubMed Google Scholar
S.D. West, D.J. Nicoll, T.M. Wallace, D.R. Matthews, J.R. Stradling, Effect of CPAP on insulin resistance and HbA1c in men with obstructive sleep apnoea and type 2 diabetes. Thorax 62(11), 969–974 (2007)
PubMed Central PubMed Google Scholar
S. Surani, S. Subramanian, Effect of continuous positive airway pressure therapy on glucose control. World J. Diabetes 3(4), 65–70 (2012)
PubMed Central PubMed Google Scholar
S. Pamidi, Abstract #39588. American Thoracic Society 2013 International Conference, Philadelphia, May 17–22, 2013
D. Kapoor, H. Aldred, S. Clark, K.S. Channer, T.H. Jones, Clinical and biochemical assessment of hypogonadism in men with type 2 diabetes: correlations with bioavailable testosterone and visceral adiposity. Diabetes Care 30(4), 911–917 (2007)
CAS PubMed Google Scholar
M. Grossmann, M.C. Thomas, S. Panagiotopoulos, K. Sharpe, R.J. Macisaac, Low testosterone levels are common and associated with insulin resistance in men with diabetes. J. Clin. Endocrinol. Metab. 93(5), 1834–1840 (2008)
CAS PubMed Google Scholar
A.A. Al Hayek, Y.S. Khader, S. Jafal, N. Khawaja, A.A. Robert, K. Ajilouni, Prevalence of low testosterone levels in men with type 2 diabetes mellitus: a cross-sectional study. J. Fam. Community Med. 20(3), 179–186 (2013)
Google Scholar
E.L. Ding, Y. Song, V.S. Malik, S. Liu, Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA 295(11), 1288–1299 (2006)
CAS PubMed Google Scholar
G. Hackett, M. Kirby, A.J. Sinclair, Testosterone deficiency, cardiac health, and older men. Int. J. Endocrinol. (2014). doi:10.1155/2014/143763
PubMed Central PubMed Google Scholar
R. Pasquali, C. Macor, V. Vicennati, F.R. Delasio, P. Mesini, S. Boschi, F. Casimirri, R. Vettor, Effects of acute hyperinsulinemia on testosterone serum concentrations in adult obese and normal-weight men. Metabolism 46(5), 526–529 (1997)
CAS PubMed Google Scholar
S. Bhasin, G.R. Cunningham, F.J. Hayes, A.M. Matsumoto, P.J. Snyder, R.S. Swerdloff, V.M. Montori, Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. J. Clin. Endocrinol. Metab. 95(6), 2536–2559 (2010)
CAS PubMed Google Scholar
R.K. Stellato, H.A. Feldman, O. Hamdy, E.S. Horton, J.B. McKinlay, Testosterone, sex hormone-binding globulin, and the development of type 2 diabetes in middle-aged men: prospective results from the Massachusetts male aging study. Diabetes Care 23(4), 490–494 (2000)
CAS PubMed Google Scholar
E.C. Tsai, A.M. Matsumoto, W.Y. Fujimoto, E.J. Boyko, Association of bioavailable, free, and total testosterone with insulin resistance: influence of sex hormone-binding globulin and body fat. Diabetes Care 27(4), 861–868 (2004)
CAS PubMed Google Scholar
P. Marin, S. Homang, L. Jonsson, L. Sjostrom, H. Kvist, G. Holm, G. Lindstedt, P. Bjorntorp, The effects of testosterone treatment on body composition and metabolism in middle-aged obese men. Int. J. Obes. Relat. Metab. Disord. 16(12), 991–997 (1992)
CAS PubMed Google Scholar
S. Filippi, L. Vignozzi, A. Morelli, A.K. Chavalmane, E. Sarchielli, B. Fibbi, F. Saad, P. Sandner, P. Ruggiano, G.B. Vannelli, E. Mannucci, M. Maggi, Testosterone partially ameliorates metabolic profile and erectile responsiveness to PDE5 inhibitors in an animal model of male metabolic syndrome. J. Sex Med. 6(12), 3274–3288 (2009)
CAS PubMed Google Scholar
D. Goodman-Gruen, E. Barrett-Connor, Sex differences in the association of endogenous sex hormone levels and glucose tolerance status in older men and women. Diabetes Care 23(7), 912–918 (2000)
CAS PubMed Google Scholar
G. Corona, G. Rastrelli, G. Balercia, F. Lotti, A. Sforza, M. Monami, G. Forti, E. Mannucci, M. Maggi, Hormonal association and sexual dysfunction in patients with impaired fasting glucose: a cross-sectional and longitudinal study. J. Sex Med. 9(6), 1669–1680 (2012)
CAS PubMed Google Scholar
C.H. Ho, H.J. Yu, C.Y. Wang, F.S. Jaw, J.T. Hsieh, W.C. Liao, Y.S. Pu, S.P. Liu, Prediabetes is associated with an increased risk of testosterone deficiency, independent of obesity and metabolic syndrome. PLoS ONE (2013). doi:10.1371/journal.pone.0074173
Google Scholar
D. Kapoor, E. Goodwin, K.S. Channer, T.H. Jones, Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes. Eur. J. Endocrinol. 154(6), 899–906 (2006)
CAS PubMed Google Scholar
M.I. Naharci, M. Pinar, E. Bolu, A. Olgun, Effect of testosterone on insulin sensitivity in men with idiopathic hypogonadotropic hypogonadism. Endocr. Pract. 13(6), 629–635 (2007)
PubMed Google Scholar
T.H. Jones, S. Arver, H.M. Behre, J. Buvat, E. Meuleman, I. Moncada, A.M. Morales, M. Volterrani, A. Yellowlees, J.D. Howell, K.S. Channer, Testosterone replacement in hypogonadal men with type 2 diabetes and/or metabolic syndrome (the TIMES2 study). Diabetes Care 34(4), 828–837 (2011)
PubMed Central CAS PubMed Google Scholar
J. Kaur, A comprehensive review on metabolic syndrome. Cardiol Res Pract. (2014). doi:10.1155/2014/943162
Google Scholar
H. Beltran-Sanchez, M.O. Harhay, M.M. Harhay, S. McElligott, Prevalance and trends of metabolic syndrome in the adult U.S. population, 1999–2010. J. Am. Coll. Cardiol. 62(8), 697–703 (2013)
PubMed Central PubMed Google Scholar
Expert Panel on Detection, Evaluation and treatment of high cholesterol in adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel detection, evaluation and treatment of high cholesterol in adults (Adult Treatment Panel III). JAMA 285(19), 2486–2497 (2001)
Google Scholar
S.M. Grundy, J.I. Cleeman, S.R. Daniels, K.A. Donato, R.H. Eckel, B.A. Franklin, D.J. Gordon, R.M. Krauss, P.J. Savage, S.C. Smith Jr, J.A. Spertus, F. Costa, Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Executive summary. Cardiol. Rev. 13(6), 322–327 (2005)
PubMed Google Scholar
K.G. Alberti, P. Zimmet, J. Shaw, The metabolic syndrome—a new worldwide definition. Lancet 366(9491), 1059–1062 (2005)
PubMed Google Scholar
G.M. Reaven, The insulin resistance syndrome: definition and dietary approaches to treatment. Annu. Rev. Nutr. 25, 391–406 (2005)
CAS PubMed Google Scholar
R.A. DeFronzo, E. Ferrannini, Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia and atherosclerotic cardiovascular disease. Diabetes Care 14(3), 173–194 (1991)
CAS PubMed Google Scholar
C.M. Alexander, P.B. Landsman, S.M. Grundy, Metabolic syndrome and hyperglycemia: congruence and divergence. Am. J. Cardiol. 98(7), 982–985 (2006)
PubMed Google Scholar
E.J. Diamantopoulos, E.A. Andreadis, G.I. Tsourous, G.K. Ifanti, P.M. Katsanou, D.X. Georgiopoulos, C.V. Vassilopoulos, G. Dimitriadis, S.A. Raptis, Metabolic syndrome and prediabetes identify overlapping but not identical populations. Exp. Clin. Endocrinol. Diabetes 144(7), 377–383 (2006)
Google Scholar
C. Lorenzo, K. Williams, K.J. Hunt, S.M. Haffner, The National Cholesterol Education Program—Adult Treatment Panel III, International Diabetes Federation, and World Health Organization definitions of the metabolic syndrome as predictors of incident cardiovascular disease and diabetes. Diabetes Care 30(1), 8–13 (2007)
PubMed Google Scholar
C. Lorenzo, M. Okoloise, K. Williams, M.P. Stern, S.M. Haffner, The metabolic syndrome as predictor of type 2 diabetes: the San Antonio heart study. Diabetes Care 26(11), 3153–3159 (2003)
PubMed Google Scholar
Q.M. Nguyen, S.R. Srinivasan, J.H. Xu, W. Chen, G.S. Berenson, Changes in risk variables of metabolic syndrome since childhood in pre-diabetic and type 2 diabetic subjects: the Bogalusa Heart Study. Diabetes Care 31(10), 2044–2049 (2008)
PubMed Central CAS PubMed Google Scholar
J.A. Morrison, L.A. Friedman, P. Wang, C.J. Glueck, Metabolic syndrome in childhood predicts adult metabolic syndrome and type 2 diabetes mellitus 25 to 30 years later. J. Pediatr. 152(2), 201–206 (2008)
CAS PubMed Google Scholar
H. Florez, M.G. Temprosa, T.J. Orchard, K.J. Mather, S.M. Marcovina, E. Barrett-Connor, E. Horton, C. Saudek, X.F. Pi-Sunyer, R.E. Ratner, R.B. Goldberg, Metabolic syndrome components and their response to lifestyle and metformin interventions are associated with differences in diabetes risk in persons with impaired glucose tolerance. Diabetes Obese Metab. 16(4), 325–333 (2014)
Google Scholar
S.M. Grundy, Pre-diabetes, metabolic syndrome, and cardiovascular risk. J. Am. Coll. Cardiol. 59(7), 635–643 (2012)
CAS PubMed Google Scholar
T.J. Orchard, M. Temprosa, R. Goldberg, S. Haffner, R. Ratner, S. Marcovina, S. Fowler, The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: the Diabetes Prevention Program randomized trial. Ann. Intern. Med. 142(8), 611–619 (2005)
PubMed Central CAS PubMed Google Scholar
J.L. Chiasson, R.G. Josse, R. Gomis, M. Hanefeld, A. Karasik, M. Laakso, Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial. JAMA 290(4), 486–494 (2003)
CAS PubMed Google Scholar
R. Rajagopalan, S. Iyer, M. Khan, Effect of pioglitazone on metabolic syndrome risk factors: results of double-blind, multicenter, randomized clinical trials. Curr. Med. Res. Opin. 21(1), 163–172 (2005)
CAS PubMed Google Scholar
S. Li, H.J. Shin, E.L. Ding, R.M. van Dam, Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA 302(2), 179–188 (2009)
CAS PubMed Google Scholar
A.G. Tabak, M. Cartensen, D.R. Witte, E.J. Brunner, M.J. Shipley, M. Jokela, M. Roden, M. Kivimaki, C. Herder, Adiponectin trajectories before type 2 diabetes diagnosis. Diabetes Care 35(12), 2540–2547 (2012)
PubMed Central CAS PubMed Google Scholar
H. Kim, J. Jo, J.E. Lim, Y.D. Yun, S.J. Baek, T. Lee, K.B. Huh, S.H. Jee, Adiponectin as predictor for diabetes among pre-diabetic groups. Endocrine 44(2), 411–418 (2013)
CAS PubMed Google Scholar
M.Y. Donath, D.M. Schumann, M. Faulenbach, H. Ellingsgaard, A. Perren, J.A. Ehses, Islet inflammation in type 2 diabetes: from metabolic stress to therapy. Diabetes Care 31(Suppl 2), S161–S164 (2008)
CAS PubMed Google Scholar
C.M. Larsen, M. Faulenbach, A. Vaag, A. Volund, J.A. Ehses, B. Seifert, T. Mandrup-Poulsen, M.Y. Donath, Interleukin-1-receptor antagonist in type 2 diabetes mellitus. N. Engl. J. Med. 356(15), 1517–1526 (2007)
CAS PubMed Google Scholar
M. Carstensen, C. Herder, M. Kivimaki, M. Jokela, M. Roden, M.J. Shipley, D.R. Witte, E.J. Brunner, A.G. Tabak, Accelereated increase in serum interleukin-1 receptor antagonist starts 6 years before diagnosis of type 2 diabetes: Whitehall II prospective cohort study. Diabetes 59(5), 1222–1227 (2010)
PubMed Central CAS PubMed Google Scholar
T.J. Wang, M.G. Larson, R.S. Vasan, S. Cheng, E.P. Rhee, E. McCabe, G.D. Lewis, C.S. Fox, P.F. Jacques, C. Fernandez, C.J. O’Donnell, S.A. Carr, V.K. Mootha, J.C. Florez, A. Souza, O. Melander, C.B. Clish, R.E. Gerszten, Metabolite profiles and the risk of developing diabetes. Nat. Med. 17(4), 448–453 (2011)
PubMed Central PubMed Google Scholar
R. Wang-Sattler, Z. Yu, C. Herder, A.C. Messias, A. Floegel, Y. He, K. Heim, M. Campillos, C. Holzapfel, B. Thorand, H. Grallert, T. Xu, E. Bader, C. Huth, K. Mittelstrass, A. Doring, C. Meisinger, C. Gieger, C. Prehn, W. Roemisch-Margl, M. Carstensen, L. Xie, H. Yamanaka-Okumura, G. Xing, U. Ceglarek, J. Thiery, G. Giani, H. Lickert, X. Lin, Y. Li, H. Boeing, H. Joost, M. Hrabé de Angelis, W. Rathmann, K. Suhre, H. Prokisch, A. Peters, T. Meitinger, M. Roden, H. Wichmann, T. Pischon, J. Adamski, T. Illig, Novel biomarkers for pre-diabetes identified by metabolomics. Mol. Syst. Biol. 8, 615 (2012)
PubMed Central PubMed Google Scholar
A. Floegel, N. Stefan, Z. Yu, K. Mühlenbruch, D. Drogan, H. Joost, A. Fritsche, H. Häring, M. Hrabe de Angelis, A. Peters, M. Roden, C. Prehn, R. Wang-Sattler, T. Illig, M.B. Schulze, J. Adamski, H. Boeing, T. Pischon, Identifcation of serum metabolites associated with risk of type 2 diabetes using a targeted metabolomics approach. Diabetes 62(2), 639–648 (2013)
PubMed Central CAS PubMed Google Scholar
W.E. Gall, K. Beebe, K.A. Lawton, K. Adam, M.W. Mitchell, P.J. Nakhle, J.A. Ryals, M.V. Milburn, M. Nannipieri, S. Camastra, A. Natali, E. Ferrannini, RISC Study Group, α-Hydroxybutyrate is an early biomarker of insulin resistance and glucose intolerance in a nondiabetic population. PLoS ONE 5(5), e10883 (2010)
PubMed Central PubMed Google Scholar
E. Ferranini, A. Natali, S. Camastra, M. Nannipieri, A. Mari, K. Adam, M.V. Milburn, G. Kastenmüller, J. Adamski, T. Tuomi, V. Lyssenko, L. Groop, W.E. Gall, Early metabolic markers of the development of dysglycemia and type 2 diabetes and their physiological significance. Diabetes 62(5), 1730–1737 (2013)
Google Scholar
E. Selvin, A.M. Rawlings, M. Grams, R. Klein, A.R. Sharrett, M. Steffes, J. Coresh, Fructosamine and glycated albumin for risk stratification and prediction of incident diabetes and microvascular complications: a prospective cohort analysis of the Atherosclerosis Risk in Communities (ARIC) study. Lancet Diabetes Endocrinol. 2(4), 279–288 (2014)
PubMed Google Scholar
J.M. Pappachan, F.A. Antonio, M.E. Edavalath, A. Mukherjee, Non-alcoholic fatty liver disease: a diabetologist’s perspective. Endocrine 45(3), 334–353 (2014)
Google Scholar
C.P. Day, O.F. James, Steatohepatitis: a tale of two “hits”? Gastroenterology 114(4), 842–845 (1998)
CAS PubMed Google Scholar
H. Tilg, A.R. Moschen, Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis. Hepatology 52(5), 1836–1846 (2010)
CAS PubMed Google Scholar
M. Sargin, O. Uygur-Bayramiçli, H. Sargin, E. Orbay, A. Yayla, Association of nonalcoholic fatty liver disease with insulin resistance: is OGTT indicated in nonalcoholic fatty liver disease? J. Clin. Gastroenterol. 37(5), 399–402 (2003)
CAS PubMed Google Scholar
V.W.S. Wong, A.Y. Hui, S.W.C. Tsang, J.L.Y. Chan, G.L.H. Wong, A.W.H. Chan, W.Y. So, A.Y.S. Cheng, P.C.Y. Tong, F.K.L. Chan, J.J.Y. Sung, H.L.Y. Chan, Prevalence of undiagnosed diabetes and postchallenge hyperglycaemia in Chinese patients with non-aloholic fatty liver disease. Aliment. Pharmacol. Ther. 24(8), 1215–1222 (2006)
CAS PubMed Google Scholar
J.W. Yun, Y.K. Cho, J.H. Park, H.J. Kim, D.I. Park, C.I. Sohn, W.K. Jeon, B.I. Kim, Abnormal glucose tolerance in young male patients with nonalcoholic fatty liver disease. Liver Int. 29(4), 525–529 (2009)
PubMed Central CAS PubMed Google Scholar
C. Ortiz-Lopez, R. Lomonaco, B. Orsak, J. Finch, Z. Chang, V.G. Kochunov, J. Hardies, K. Cusi, Prevalence of prediabetes and diabetes and metabolic profile of patients with nonalcoholic fatty liver disease (NAFLD). Diabetes Care 35(4), 873–878 (2012)
PubMed Central CAS PubMed Google Scholar
S. Zelber-Sagi, R. Lotan, O. Shibolet, M. Webb, A. Buch, D. Nitzan-Kaluski, Z. Halpern, E. Santo, R. Oren, Non-alcoholic fatty liver disease independently predicts prediabetes during a 7-year prospective follow-up. Liver Int. 33(9), 1406–1412 (2013)
CAS PubMed Google Scholar
B. Vozarova, N. Stefan, R.S. Lindsay, A. Saremi, R.E. Pratley, C. Bogardus, P.A. Tataranni, High alanine aminotransferase is associated with decreased hepatic insulin sensitivity and predicts the development of type 2 diabetes. Diabetes 51(6), 1889–1895 (2002)
CAS PubMed Google Scholar
A.J. Hanley, K. Williams, A. Festa, L.E. Wagenknecht, R.B. D’Agostino Jr, J. Kempf, B. Zinman, S.M. Haffner, Insulin resistance atherosclerosis study, elevations in markers of liver injury and risk of type 2 diabetes: the insulin resistance atherosclerosis study. Diabetes 53(10), 2623–2632 (2004)
CAS PubMed Google Scholar
M. Nannipieri, C. Gonzales, S. Baldi, R. Posadas, K. Williams, S.M. Haffner, M.P. Stern, E. Ferrannini, Mexico City Diabetes Study, liver enzymes, the metabolic syndrome, and incident diabetes: the Mexico City diabetes study. Diabetes Care 28(7), 1757–1762 (2005)
CAS PubMed Google Scholar
Y. Doi, M. Kubo, K. Yonemoto, T. Ninomiya, M. Iwase, Y. Tanizaki, K. Shikata, M. Iida, Y. Kiyohara, Liver enzymes as predictor for incident diabetes in a Japanese population: the Hisayama study. Obesity (Silver Spring) 15(7), 1841–1850 (2007)
CAS Google Scholar
E.S. Ford, M.B. Schulze, M.M. Bergmann, C. Thamer, H.G. Joost, H. Boeing, Liver enzymes and incident diabetes: findings from the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. Diabetes Care 31(6), 1138–1143 (2008)
PubMed Google Scholar
A. Fraser, R. Harris, N. Sattar, S. Ebrahim, G.D. Smith, D.A. Lawlor, Alanine aminotransferase, gamma-glutamyltransferase, and incident diabetes: the British Women’s Heart and Health Study and meta-analysis. Diabetes Care 32(4), 741–750 (2009)
PubMed Central CAS PubMed Google Scholar
G. Bedogni, S. Bellentani, L. Miglioli, F. Masutti, M. Passalacqua, A. Castiglione, C. Tiribelli, The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol. 6, 33 (2006)
PubMed Central PubMed Google Scholar
B. Balkau, C. Lange, S. Vol, F. Fumeron, F. Bonnet, Group Study D.E.S.I.R., Nine-year incident diabetes is predicted by fatty liver indices: the French D.E.S.I.R. study. BMC Gastroenterol. 10, 56 (2010)
PubMed Central PubMed Google Scholar
I. Rückert, M. Heier, W. Rathmann, S.E. Baumeister, A. Döring, C. Meisinger, Association between markers of fatty liver disease and impaired glucose regulation in men and women from the general population: the KORA-F4-Study. PLoS ONE 6(8), e22932 (2011)
PubMed Central PubMed Google Scholar
N. Stefan, A.M. Hennige, H. Staiger, J. Machann, F. Schick, S.M. Kröber, F. Machicao, A. Fritsche, H. Häring, α2-Heremans-Schmid glycoprotein/fetuin-A is associated with insulin resistance and fat accumulation in the liver in humans. Diabetes Care 29(4), 853–857 (2006)
CAS PubMed Google Scholar
H. Ou, Y. Yang, H. Wu, J. Wu, F. Lu, C. Chang, Increased fetuin-A concentrations in impaired glucose tolerance with or without nonalcoholic fatty liver disease, but not impaired fasting glucose. J. Clin. Endocrinol. Metab. 97(12), 4717–4723 (2012)
CAS PubMed Google Scholar
E. Giovannucci, D.M. Harlan, M.C. Archer, R.M. Bergnestal, S.M. Gapstur, L.A. Habel, M. Pollak, J.G. Regensteiner, D. Yee, Diabetes and Cancer. A consensus report. Diabetes Care 33(7), 1674–1685 (2010)
PubMed Central PubMed Google Scholar
Y. Huang, X. Cai, M. Qiu, P. Chen, H. Tang, Y. Hu, Y. Huang, Prediabetes and the risk of cancer: a meta-analysis. Diabetologia (2014). doi:10.1007/s00125-014-3361-2
Google Scholar
S. Gao, A. Li, F. Liu et al., NCOA5 haploinsufficency results in glucose intolerance and subsequent heaptocellualr carcinoma. Cancer Cell 24, 725–737 (2013)
PubMed Central CAS PubMed Google Scholar
A. Leone, E. DiGennaro, F. Bruzzese, A. Avallone, A. Budillon, New perspective for an old antidiabteic drug: metformin as anticancer agent. Cancer Treat Res 159, 355–376 (2014)
PubMed Google Scholar
M. Bergman, R. Dankner, J. Roth, K.M. Venkat Narayan, Are current diagnostic guidelines delaying early detection of dysglycemic states? Time for new approaches. Endocrine 44(1), 66–69 (2013)
CAS PubMed Google Scholar
M. Bergman, Pathophysiology of prediabetes and treatment implications for the prevention of type 2 diabetes mellitus. Endocrine 43(3), 504–513 (2013)
CAS PubMed Google Scholar
M. Bergman, Inadequacies of current approaches to prediabetes and diabetes prevention. Endocrine 44(3), 623–633 (2013)
CAS PubMed Google Scholar

Download references